🇺🇸 FDA
Patent

US 10920227

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

granted A61PA61P21/02A61P25/28

Quick answer

US patent 10920227 (Compositions and methods of treating amyotrophic lateral sclerosis (ALS)) held by VOYAGER THERAPEUTICS, INC. expires Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 11 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P21/02, A61P25/28, A61P43/00